Wave Life Sciences Ltd. CEO Paul Bolno's 2018 pay jumps 83% to $5.8M
Wave Life Sciences Ltd. reports 2018 executive compensation
By ExecPay News
Published: June 26, 2019
Wave Life Sciences Ltd. reported fiscal year 2018 executive compensation information on June 26, 2019.
In 2018, five executives at Wave Life Sciences Ltd. received on average a compensation package of $2.7M, a 87% increase compared to previous year.
Average pay of disclosed executives at Wave Life Sciences Ltd.
Paul B. Bolno, Chief Executive Officer, received $5.8M in total, which increased by 83% compared to 2017. 48% of Bolno's compensation, or $2.8M, was in option awards. Bolno also received $304K in non-equity incentive plan, $541K in salary, $2.2M in stock awards, as well as $10K in other compensation.
Michael Panzara, Chief Medical Officer, received a compensation package of $2.2M, which increased by 108% compared to previous year. 41% of the compensation package, or $900K, was in option awards.
Chandra Vargeese, Senior Vice President, Drug Discovery, earned $2.2M in 2018, a 88% increase compared to previous year.
Keith C. Regnante, Chief Financial Officer, received $1.7M in 2018, which increases by 122% compared to 2017.
Christopher Francis, Senior Vice President, Corporate Development, Head of Emerging Areas, earned $1.7M in 2018, a 52% increase compared to previous year.
Related executives
Keith Regnante
Wave Life Sciences Ltd.
Chief Financial Officer
Christopher Francis
Wave Life Sciences Ltd.
Senior Vice President, Corporate Development, Head of Emerging Areas
Michael Panzara
Wave Life Sciences Ltd.
Chief Medical Officer
Chandra Vargeese
Wave Life Sciences Ltd.
Chief Technology Officer
Paul Bolno
Wave Life Sciences Ltd.
Chief Executive Officer
You may also like
Source: SEC filing on June 26, 2019.